EXTON, Pa., Dec. 10, 2019 /PRNewswire/ -- Biogen's Vumerity (diroximel fumarate), a monomethyl fumarate prodrug, was approved by the FDA on October 30 th for the treatment of relapsing forms of ...

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Ltd (Cycle) has today welcomed the news that multiple sclerosis (MS) patients in the US currently being treated with Gilenya, or generic fingolimod to ...

Gilenya may also be prescribed to treat clinically isolated syndrome (CIS). People with CIS often (but not always) develop MS later on. If you and your doctor agree that Gilenya is working well for ...

WASHINGTON, April 17 (Reuters) - The U.S. Supreme Court on Monday declined to hear Novartis Pharmaceuticals Corp's (NOVN.S), opens new tab bid to revive a key patent on its blockbuster multiple ...

If you have a certain type of multiple sclerosis (MS), your doctor might suggest Gilenya (fingolimod) as a treatment option for you. Gilenya is a prescription medication that’s used to treat the ...

More than a year after it issued an initial warning about the use of the multiple sclerosis (MS) drug Gilenya (fingolimod) after it was associated with an increased risk of adverse cardiovascular ...

As Novartis awaits the U.S. Supreme Court’s decision on whether to take up its Gilenya patent dispute, the high court has cleared the way for copies of the nearly $3 billion multiple sclerosis ...